INSULIN GLARGINE-AGLR

INSULIN GLARGINE-AGLR was reported 77 times

INSULIN GLARGINE-AGLR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHEUMATOID MENINGITIS 1 0.0312
1 MEDICAL DEVICE SITE CELLULITIS 1 0.0172
2 MEDICAL DEVICE SITE ABSCESS 1 0.0145
3 VEXAS SYNDROME 1 0.0104
4 CAPILLARITIS 1 0.0036
5 TOTAL LUNG CAPACITY ABNORMAL 1 0.0026
6 SENSORIMOTOR DISORDER 1 0.0020
7 PULMONARY VASCULITIS 1 0.0019
8 SPIROMETRY ABNORMAL 1 0.0017
9 MITE ALLERGY 1 0.0015
10 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
11 HERPES ZOSTER DISSEMINATED 1 0.0012
12 MYCOTIC ALLERGY 1 0.0012
13 DUST ALLERGY 1 0.0010
14 ACCIDENTAL UNDERDOSE 13 0.0009
15 CONJUNCTIVITIS ALLERGIC 1 0.0007
16 NEURITIS 1 0.0006
17 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
18 DEVICE INFUSION ISSUE 1 0.0004
19 PHYSICAL DECONDITIONING 1 0.0004
20 BLOOD CHLORIDE DECREASED 1 0.0004
21 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
22 RESPIRATORY SYMPTOM 1 0.0004
23 EYELID MARGIN CRUSTING 1 0.0003
24 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
25 PRODUCT STORAGE ISSUE 1 0.0003
26 PAPILLOEDEMA 1 0.0002
27 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
28 NEUROLOGICAL SYMPTOM 1 0.0002
29 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
30 POSTOPERATIVE WOUND INFECTION 1 0.0001
31 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
32 CARDIAC OPERATION 1 0.0001
33 GRIP STRENGTH DECREASED 1 0.0001
34 ARTERIOSCLEROSIS 1 0.0001
35 FULL BLOOD COUNT ABNORMAL 1 0.0001
36 HYPOACUSIS 4 0.0001
37 WOUND INFECTION 1 0.0001
38 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
39 INTESTINAL PERFORATION 1 0.0001
40 VASCULITIS 1 0.0001
41 BLOOD GLUCOSE INCREASED 16 0.0001
42 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
43 NODULE 1 0.0001
44 INJECTION SITE HAEMORRHAGE 6 0.0001
45 DEVICE OCCLUSION 1 0.0001
46 IMPAIRED QUALITY OF LIFE 1 0.0001
47 HYPERTHYROIDISM 1 0.0001
48 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
49 THERAPY PARTIAL RESPONDER 1 0.0001
50 HYPOTHYROIDISM 2 0.0001
51 BLOOD POTASSIUM INCREASED 1 0.0001
52 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
53 LYMPHOCYTE COUNT DECREASED 1 0.0001
54 GASTROENTERITIS VIRAL 1 0.0001
55 HEPATIC CIRRHOSIS 1 0.0001
56 PULMONARY FIBROSIS 1 0.0001
57 POST PROCEDURAL COMPLICATION 1 0.0001
58 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
59 UPPER LIMB FRACTURE 1 0.0001
60 INCORRECT DOSE ADMINISTERED 11 0.0000
61 EATING DISORDER 1 0.0000
62 PRODUCT DISPENSING ERROR 1 0.0000
63 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
64 DIABETIC KETOACIDOSIS 1 0.0000
65 LOCALISED INFECTION 1 0.0000
66 PRESYNCOPE 1 0.0000
67 ENCEPHALOPATHY 1 0.0000
68 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
69 INJECTION SITE BRUISING 3 0.0000
70 EAR INFECTION 1 0.0000
71 LIMB INJURY 1 0.0000
72 FEELING COLD 1 0.0000
73 HAEMOPTYSIS 1 0.0000
74 PRODUCT STORAGE ERROR 3 0.0000
75 ASCITES 1 0.0000
76 PRODUCT DOSE OMISSION ISSUE 10 0.0000
77 HEPATIC FAILURE 1 0.0000
78 VISUAL IMPAIRMENT 4 0.0000
79 BLOOD CREATININE INCREASED 2 0.0000
80 DELIRIUM 1 0.0000
81 HYPOXIA 1 0.0000
82 LYMPHADENOPATHY 1 0.0000
83 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
84 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
85 BLINDNESS 1 0.0000
86 ROAD TRAFFIC ACCIDENT 1 0.0000
87 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
88 THERAPY NON-RESPONDER 1 0.0000
89 RENAL DISORDER 1 0.0000
90 PRODUCTIVE COUGH 1 0.0000
91 BLOOD GLUCOSE DECREASED 1 0.0000
92 LUNG DISORDER 1 0.0000
93 FLUID RETENTION 1 0.0000
94 OEDEMA 1 0.0000
95 ASTHMA 2 0.0000
96 DYSPHONIA 1 0.0000
97 NASAL CONGESTION 1 0.0000
98 WHEEZING 1 0.0000
99 CATARACT 1 0.0000
100 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
101 DISCOMFORT 1 0.0000
102 RHINORRHOEA 1 0.0000
103 SLEEP DISORDER 1 0.0000
104 HALLUCINATION 1 0.0000
105 THROMBOSIS 1 0.0000
106 RENAL IMPAIRMENT 1 0.0000
107 SKIN EXFOLIATION 1 0.0000
108 ADVERSE EVENT 1 0.0000
109 PULMONARY EMBOLISM 1 0.0000
110 DYSPEPSIA 1 0.0000
111 CONDITION AGGRAVATED 3 0.0000
112 INJECTION SITE PAIN 3 0.0000
113 SINUSITIS 1 0.0000
114 HAEMOGLOBIN DECREASED 1 0.0000
115 ILLNESS 1 0.0000
116 HAEMORRHAGE 1 0.0000
117 PLATELET COUNT DECREASED 1 0.0000
118 INFLUENZA 1 0.0000
119 PALPITATIONS 1 0.0000
120 INJECTION SITE ERYTHEMA 1 0.0000
121 HYPERHIDROSIS 1 0.0000
122 VISION BLURRED 1 0.0000
123 COUGH 2 0.0000
124 ANXIETY 2 0.0000
125 BLOOD PRESSURE INCREASED 1 0.0000
126 TREMOR 1 0.0000
127 NO ADVERSE EVENT 1 0.0000
128 NASOPHARYNGITIS 1 0.0000
129 CHEST PAIN 1 0.0000
130 ASTHENIA 2 0.0000
131 DRUG INEFFECTIVE 7 0.0000
132 DYSPNOEA 3 0.0000
133 ANAEMIA 1 0.0000
134 GAIT DISTURBANCE 1 0.0000
135 ALOPECIA 1 0.0000
136 HYPOTENSION 1 0.0000
137 SOMNOLENCE 1 0.0000
138 CONSTIPATION 1 0.0000
139 MALAISE 2 0.0000
140 DECREASED APPETITE 1 0.0000
141 FEELING ABNORMAL 1 0.0000
142 DIZZINESS 2 0.0000
143 DEATH 3 0.0000
144 PAIN IN EXTREMITY 1 0.0000
145 FATIGUE 2 0.0000
146 NAUSEA 2 0.0000
147 RASH 1 0.0000
148 OFF LABEL USE 2 0.0000
149 DIARRHOEA 1 0.0000